136 related articles for article (PubMed ID: 18773393)
1. Sustained release of drugs dispersed in polymer nanoparticles.
Jacobson GB; Shinde R; Contag CH; Zare RN
Angew Chem Int Ed Engl; 2008; 47(41):7880-2. PubMed ID: 18773393
[No Abstract] [Full Text] [Related]
2. Formation of nanoparticles of a hydrophilic drug using supercritical carbon dioxide and microencapsulation for sustained release.
Thote AJ; Gupta RB
Nanomedicine; 2005 Mar; 1(1):85-90. PubMed ID: 17292062
[TBL] [Abstract][Full Text] [Related]
3. Application of polyhydroxyalkanoates nanoparticles as intracellular sustained drug-release vectors.
Xiong YC; Yao YC; Zhan XY; Chen GQ
J Biomater Sci Polym Ed; 2010; 21(1):127-40. PubMed ID: 20040158
[TBL] [Abstract][Full Text] [Related]
4. Controlled release of 4-nitroanisole from poly(lactic acid) nanoparticles.
Romero-Cano MS; Vincent B
J Control Release; 2002 Jul; 82(1):127-35. PubMed ID: 12106983
[TBL] [Abstract][Full Text] [Related]
5. 15. Vitamin E TPGS based nanoparticles of biodegradable polymers for controlled release of anticancer drugs: Original research article: a novel controlled release formulation for the anticancer drug paclitaxel (Taxol): PLGA nanoparticles containing vitamin E TPGS (2003).
Feng SS
J Control Release; 2014 Sep; 190():58-60. PubMed ID: 25356488
[No Abstract] [Full Text] [Related]
6. Poly(lactic acid)-coated mesoporous silica nanosphere for controlled release of venlafaxine.
Tang J; Slowing II; Huang Y; Trewyn BG; Hu J; Liu H; Lin VS
J Colloid Interface Sci; 2011 Aug; 360(2):488-96. PubMed ID: 21640356
[TBL] [Abstract][Full Text] [Related]
7. Amphiphilic polylactic acid-hyperbranched polyglycerol nanoparticles as a controlled release system for poorly water-soluble drugs: physicochemical characterization.
Gao X; Zhang X; Zhang X; Wang Y; Sun L; Li C
J Pharm Pharmacol; 2011 Jun; 63(6):757-64. PubMed ID: 21585372
[TBL] [Abstract][Full Text] [Related]
8. Nanoparticle-based topical ophthalmic formulation for sustained release of stereoisomeric dipeptide prodrugs of ganciclovir.
Yang X; Shah SJ; Wang Z; Agrahari V; Pal D; Mitra AK
Drug Deliv; 2016 Sep; 23(7):2399-2409. PubMed ID: 25564964
[TBL] [Abstract][Full Text] [Related]
9. [Preparation and drug release property of paclitaxel nanoparticles].
Wang TW; Wu Y; Li MJ; Gao HX
Zhong Yao Cai; 2009 Sep; 32(9):1447-9. PubMed ID: 20034226
[TBL] [Abstract][Full Text] [Related]
10. Plasticization and spraying of poly (DL-lactic acid) using supercritical carbon dioxide: control of particle size.
Hao J; Whitaker MJ; Wong B; Serhatkulu G; Shakesheff KM; Howdle SM
J Pharm Sci; 2004 Apr; 93(4):1083-90. PubMed ID: 14999744
[TBL] [Abstract][Full Text] [Related]
11. Copolymerization of D,L-lactide and glycolide in supercritical carbon dioxide with zinc octoate as catalyst.
Mazarro R; de Lucas A; Gracia I; Rodríguez JF
J Biomed Mater Res B Appl Biomater; 2008 Apr; 85(1):196-203. PubMed ID: 17854066
[TBL] [Abstract][Full Text] [Related]
12. Development of biodegradable nanoparticles for liver-specific ribavirin delivery.
Ishihara T; Kaneko K; Ishihara T; Mizushima T
J Pharm Sci; 2014 Dec; 103(12):4005-4011. PubMed ID: 25335768
[TBL] [Abstract][Full Text] [Related]
13. Encapsulation of beraprost sodium in nanoparticles: analysis of sustained release properties, targeting abilities and pharmacological activities in animal models of pulmonary arterial hypertension.
Ishihara T; Hayashi E; Yamamoto S; Kobayashi C; Tamura Y; Sawazaki R; Tamura F; Tahara K; Kasahara T; Ishihara T; Takenaga M; Fukuda K; Mizushima T
J Control Release; 2015 Jan; 197():97-104. PubMed ID: 25449809
[TBL] [Abstract][Full Text] [Related]
14. PLA/PLGA nanoparticles for sustained release of docetaxel.
Musumeci T; Ventura CA; Giannone I; Ruozi B; Montenegro L; Pignatello R; Puglisi G
Int J Pharm; 2006 Nov; 325(1-2):172-9. PubMed ID: 16887303
[TBL] [Abstract][Full Text] [Related]
15. [Preparation of biodegradable and sustained release gel of tinidazole].
Qin Y; Li L; Li W; Yuan M; Zhu Y; Guo S
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2007 Feb; 24(1):87-90. PubMed ID: 17333898
[TBL] [Abstract][Full Text] [Related]
16. Design and in vitro assessment of L-lactic acid-based copolymers as prodrug and carrier for intravitreal sustained L-lactate release to reverse retinal arteriolar occlusions.
Veurink M; Asmus L; Hennig M; Kaufmann B; Bagnewski L; Heiligenhaus A; Mendrinos E; Pournaras CJ; Gurny R; Möller M
Eur J Pharm Sci; 2013 May; 49(2):233-40. PubMed ID: 23500039
[TBL] [Abstract][Full Text] [Related]
17. High glycolic poly (DL lactic co glycolic acid) nanoparticles for controlled release of meropenem.
Nandakumar V; Geetha V; Chittaranjan S; Doble M
Biomed Pharmacother; 2013 Jun; 67(5):431-6. PubMed ID: 23583192
[TBL] [Abstract][Full Text] [Related]
18. Release retardation of model protein on polyelectrolyte-coated PLGA nano- and microparticles.
Nugraha C; Bora M; Venkatraman SS
PLoS One; 2014; 9(3):e92393. PubMed ID: 24647768
[TBL] [Abstract][Full Text] [Related]
19. [Preparation and evaluation of sustained-release microsphere of Sanguis Draconis in vitro].
Ding LY; Xia PF; Yang CQ; Lin YL; Wang J
Zhongguo Zhong Yao Za Zhi; 2007 Mar; 32(5):388-90. PubMed ID: 17511140
[TBL] [Abstract][Full Text] [Related]
20. The influence of the use of viscosifying agents as dispersion media on the drug release properties from PLGA nanoparticles.
Dillen K; Weyenberg W; Vandervoort J; Ludwig A
Eur J Pharm Biopharm; 2004 Nov; 58(3):539-49. PubMed ID: 15451528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
